ATTENTIN cpr 20 mg 30 pce
7680674750031
CH-67475
N06BA02
01.10.2.
Reimbursement limitations:
ATTENTIN
Uniquement en traitement de seconde ligne du trouble du déficit de l’attention et de l’hyperactivité …
1 / 3
google
Details
- Product number
- 6747503
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- dexamfetamini sulfas 20 mg corresp. dexamfetaminum 14.68 mg, isomaltum 137.7 mg, E 172 (rubrum), magnesii stearas, pro compresso.
Articles (1)
Attentin 20 mg,Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | WIZUS |
|
(N/A)
|
14.68 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
137.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 115.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2021
Authorization holder
Salmon Pharma GmbH
4052 Basel
Authorization information
- Swissmedic authorization number
- 67475
- Drug name
- Attentin, Tabletten
- Galenic form
- TAB
- ATC Code
- N06BA02
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 16/11/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 01.10.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ATTENTIN cpr 20 mg 30 pce
- Description (DE)
- ATTENTIN Tabl 20 mg 30 Stk
- Market launch
- 16/11/2020
- Narcotic (BTM)
- A